Lumateperone for the Prevention of Relapse in Schizophrenia: New sNDA Submitted

Positive Phase 2b Results: BPL-003 for Patients With Treatment-Resistant Depression

https://www.psychiatrictimes.com/view/recent-updates-in-psychopharmacology-insights-in-schizophrenia-adhd-and-treatment-resistant-depression?utm_source=chatgpt.com